
|Articles|January 5, 2023
Egnyte Announces New Offering for Early-Stage Life Science Startups
Advertisement
Egnyte announced it will be providing early-stage life sciences innovators complimentary access to their Egnyte for Life Sciences platform. This offer is designed to accelerate “time to patient” for life sciences innovators and will give companies a full year of access to Egnyte’s platform.
Read more about the new offering
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato
2
ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models
3
Operational Pragmatism in ePRO-heavy trials
4
Could Selective Safety Data Collection Become the Industry's New Default?
5




